Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+900.00%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
North American Cannabis Holdings, Inc. (USMJ) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 900.0% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of -6.6%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue -6.6%, EPS 0.0%, free cash flow +169.3% with operating margin -5.9% and ROIC 3.8%. Valuation sits in the middle of the pack at price/sales 7.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines USMJ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
USMJ
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
USMJ Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for USMJ and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$858.2K
-19.0% YoY
FY Net Income
-$5.3K
-105.5% YoY
Free Cash Flow
$255.2K
+181.9% YoY
Revenue Growth
-6.6%
EPS Growth
+0.0%
Gross Margin
68.4%
Net Margin
-355.4%
Income statement
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 191K | 204K | 955K | 1M | 858K |
| Gross Profit | 130K | 134K | 476K | 610K | 479K |
| Operating Income | -11K | -131K | 6K | 96K | -5K |
| EBITDA | -441K | -612K | 6K | 96K | -5K |
| Net Income | -678K | -819K | 6K | 96K | -5K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | 61K | 6K | 85K | 80K | 50K |
| Total Assets | 407K | 394K | 530K | 1M | 779K |
| Total Liabilities | 2M | 2M | 2M | 2M | 3M |
| Shareholder Equity | -2M | -2M | -2M | -1M | -2M |
| Total Debt | 1M | 1M | 1M | 1M | 2M |
| Net Debt | 1M | 1M | 1M | 1M | 2M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
255K
+181.9% YoY
Capital Expenditures
0
Free Cash Flow
255K
+181.9% YoY
Key ratios
Gross Margin
68.4%
Operating Margin
-5.9%
Net Margin
-355.4%
ROE
40.3%
Debt / Equity
-0.74x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.